EcoDrugPlus

Ensembl ID : YBR031W
Description: -
116 Possible Orthologues:

Title

Ensembl ID : YBR048W
Description: -
107 Possible Orthologues:

Title

Ensembl ID : YBR084C-A
Description: -
121 Possible Orthologues:

Title

Ensembl ID : YBR133C
Description: -
68 Possible Orthologues:

Title

Ensembl ID : YBR145W
Description: -
249 Possible Orthologues:

Title

Ensembl ID : YBR160W
Description: -
81 Possible Orthologues:

Title

Ensembl ID : YBR181C
Description: -
114 Possible Orthologues:

Title

Ensembl ID : YBR189W
Description: -
89 Possible Orthologues:

Title

Ensembl ID : YBR191W
Description: -
107 Possible Orthologues:

Title

Ensembl ID : YBR204C
Description: -
1827 Possible Orthologues:

Title

Ensembl ID : YBR229C
Description: -
135 Possible Orthologues:

Title

Ensembl ID : YBR299W
Description: -
322 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).